These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 25674175)

  • 1. Systemic effects of inhaled corticosteroids: an overview.
    Pandya D; Puttanna A; Balagopal V
    Open Respir Med J; 2014; 8():59-65. PubMed ID: 25674175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciclesonide versus other inhaled corticosteroids for chronic asthma in children.
    Kramer S; Rottier BL; Scholten RJ; Boluyt N
    Cochrane Database Syst Rev; 2013 Feb; (2):CD010352. PubMed ID: 23450613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled corticosteroids in children with persistent asthma: effects on growth.
    Zhang L; Prietsch SO; Ducharme FM
    Evid Based Child Health; 2014 Dec; 9(4):829-930. PubMed ID: 25504972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICS.
    Latorre M; Novelli F; Vagaggini B; Braido F; Papi A; Sanduzzi A; Santus P; Scichilone N; Paggiaro P
    Pulm Pharmacol Ther; 2015 Feb; 30():44-50. PubMed ID: 25445928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of inhaled budesonide: clinical manifestations of systemic corticosteroid-related adverse effects.
    Christensson C; Thorén A; Lindberg B
    Drug Saf; 2008; 31(11):965-88. PubMed ID: 18840017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled corticosteroids in children with asthma: pharmacologic determinants of safety and efficacy and other clinical considerations.
    Gulliver T; Morton R; Eid N
    Paediatr Drugs; 2007; 9(3):185-94. PubMed ID: 17523699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled corticosteroids in the treatment of respiratory allergy: safety vs. efficacy.
    Rizzo MC; Solé D
    J Pediatr (Rio J); 2006 Nov; 82(5 Suppl):S198-205. PubMed ID: 17136296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
    Spencer S; Evans DJ; Karner C; Cates CJ
    Cochrane Database Syst Rev; 2011 Oct; (10):CD007033. PubMed ID: 21975759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis.
    Lipworth BJ
    Arch Intern Med; 1999 May; 159(9):941-55. PubMed ID: 10326936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review.
    Dyer MJ; Halpin DM; Stein K
    BMC Fam Pract; 2006 Jun; 7():34. PubMed ID: 16753053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
    Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of the newer inhaled corticosteroids in childhood asthma.
    Randell TL; Donaghue KC; Ambler GR; Cowell CT; Fitzgerald DA; van Asperen PP
    Paediatr Drugs; 2003; 5(7):481-504. PubMed ID: 12837120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
    Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
    Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asthma medications and their potential adverse effects in the elderly: recommendations for prescribing.
    Newnham DM
    Drug Saf; 2001; 24(14):1065-80. PubMed ID: 11735662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing a fixed combination of budesonide/formoterol with other inhaled corticosteroid plus long-acting beta-agonist combinations in patients with chronic obstructive pulmonary disease: a review.
    Solidoro P; Patrucco F; Bagnasco D
    Expert Rev Respir Med; 2019 Nov; 13(11):1087-1094. PubMed ID: 31498714
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacologic characteristics and adrenal suppression with newer inhaled corticosteroids: A comparison of ciclesonide and fluticasone propionate.
    Kaliner MA
    Clin Ther; 2006 Mar; 28(3):319-31. PubMed ID: 16750447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled corticosteroids for stable chronic obstructive pulmonary disease.
    Yang IA; Fong KM; Sim EH; Black PN; Lasserson TJ
    Cochrane Database Syst Rev; 2007 Apr; (2):CD002991. PubMed ID: 17443520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled corticosteroids and risk of pneumonia in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized controlled trials.
    Yang M; Du Y; Chen H; Jiang D; Xu Z
    Int Immunopharmacol; 2019 Dec; 77():105950. PubMed ID: 31629940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids.
    O'Byrne PM; Rennard S; Gerstein H; Radner F; Peterson S; Lindberg B; Carlsson LG; Sin DD
    Respir Med; 2012 Nov; 106(11):1487-93. PubMed ID: 22902134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
    Prescrire Int; 2016 Nov; 25(176):272-277. PubMed ID: 30715829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.